We are live on ! Find out more
BHVN

Biohaven Pharmaceutical Holding Company Ltd.
BHVN

Delisted

BHVN was delisted on the 3rd of October, 2022.

Back to rankings

7 hedge funds and large institutions have $13.8M invested in Biohaven Pharmaceutical Holding Company Ltd. in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 229 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% less funds holding in top 10

Funds holding in top 10: 32 → 1 (-31)

97% less funds holding

Funds holding: 240 → 7 (-233)

99% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 229

100% less capital invested

Capital invested by funds: $8.78B → $13.8M (-$8.77B)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
7
Holders Change
-233
Holders Change %
-97.08%
% of All Funds
0.11%
Holding in Top 10
1
Holding in Top 10 Change
-31
Holding in Top 10 Change %
-96.88%
% of All Funds
0.02%
New
2
Increased
–
Reduced
4
Closed
229
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$9.87K
2
MSCM
McElhenny Sheffield Capital Management
Texas
+$4.71K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$748M
2
UOC
UBS O'Connor
Illinois
-$572M
3
HI
HBK Investments
Texas
-$537M
4
Stifel Financial
Stifel Financial
Missouri
-$464M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$349M
Name Holding Trade Value Shares
Change 		Change in
Stake
Rafferty Asset Management
101
Rafferty Asset Management
New York
– -$6.94M -45,902 Closed
AIP
102
ARS Investment Partners
New York
– -$6.94M -45,892 Closed
Dimensional Fund Advisors
103
Dimensional Fund Advisors
Texas
– -$6.85M -45,333 Closed
New York State Common Retirement Fund
104
New York State Common Retirement Fund
New York
– -$6.81M -45,063 Closed
HWAM
105
Hennion & Walsh Asset Management
New Jersey
– -$6.45M -42,694 Closed
Nomura Holdings
106
Nomura Holdings
Japan
– -$5.62M -38,177 Closed
Man Group
107
Man Group
United Kingdom
– -$5.77M -38,145 Closed
HF
108
HRT Financial
New York
– -$5.73M -37,901 Closed
Susquehanna International Group
109
Susquehanna International Group
Pennsylvania
– -$5.53M -36,591 Closed
BNP Paribas Financial Markets
110
BNP Paribas Financial Markets
France
– -$5.49M -36,295 Closed
State of New Jersey Common Pension Fund D
111
State of New Jersey Common Pension Fund D
New Jersey
– -$5.46M -36,100 Closed
PCM
112
Prelude Capital Management
New York
– -$5.37M -35,549 Closed
MIM
113
MetLife Investment Management
New Jersey
– -$5.04M -33,319 Closed
MOACM
114
Mutual of America Capital Management
New York
– -$4.83M -31,959 Closed
SEI Investments
115
SEI Investments
Pennsylvania
– -$4.66M -30,806 Closed
Jane Street
116
Jane Street
New York
– -$4.64M -30,716 Closed
AIG
117
American International Group
New York
– -$4.53M -29,981 Closed
Invesco
118
Invesco
Georgia
– -$4.45M -29,416 Closed
Ameriprise
119
Ameriprise
Minnesota
– -$4.44M -29,388 Closed
GI
120
GAMCO Investors
Connecticut
– -$4.13M -27,350 Closed
Mirae Asset Global Investments
121
Mirae Asset Global Investments
South Korea
– -$3.99M -26,380 Closed
VOYA Investment Management
122
VOYA Investment Management
Georgia
– -$3.67M -24,252 Closed
Manulife (Manufacturers Life Insurance)
123
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$3.66M -24,238 Closed
AQR Capital Management
124
AQR Capital Management
Connecticut
– -$3.27M -21,635 Closed
GC
125
Guggenheim Capital
Illinois
– -$3.22M -21,291 Closed
3 4
5
6 7

BHVN Hedge Fund Activity: Q4 2022 in Review

7 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Biohaven Pharmaceutical Holding Company Ltd. (BHVN) for Q4 2022, worth a combined $13.8M — down 100% from $8.78B a quarter earlier.

Sellers outnumbered buyers: 229 funds closed out of BHVN and 2 opened new positions — a net loss of 227 holders — while 4 trimmed existing stakes and 0 added.

The largest buyer was Blue Trust Inc, opening a new position worth an estimated $9.87K. The largest seller was BlackRock, exiting entirely with an estimated $748M sold.

  • 7 institutional investors held Biohaven Pharmaceutical Holding Company Ltd. (BHVN) as of Q4 2022, down from 240 in Q3 2022.
  • Funds reported $13.8M of Biohaven Pharmaceutical Holding Company Ltd. stock for Q4 2022, down 100% quarter-over-quarter.
  • 2 funds opened new Biohaven Pharmaceutical Holding Company Ltd. positions in Q4 2022 and 229 closed out, a net change of -227 holders.
  • The largest Biohaven Pharmaceutical Holding Company Ltd. buyer in Q4 2022 was Blue Trust Inc, an estimated $9.87K added.
  • The largest Biohaven Pharmaceutical Holding Company Ltd. seller in Q4 2022 was BlackRock, an estimated $748M sold.

Based on aggregated 13F filings for Q4 2022.